LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the appointment of Jane E. Henney, M.D. to its Board of Directors. Dr. Henney currently is a Professor of Medicine at the University of Cincinnati College of Medicine. With the addition of Dr. Henney, the Cubist Board of Directors consists of 11 members, 10 of whom are independent.
“Jane brings a tremendous breadth of experience from her career, and we are delighted to welcome her to our Board,” said Kenneth Bate, non-executive Chairman of the Board of Directors of Cubist. “The medical and health policy insights Jane has gained over her years as FDA Commissioner and as a leader of large and successful medical organizations will prove invaluable to Cubist as we continue to grow and expand our acute care business.”
In addition to serving as a Professor of Medicine from 2003-2008, Dr. Henney also served as the Senior Vice President and Provost of University of Cincinnati’s Academic Health Center. In 2008 Dr. Henney was appointed to her current position as a Professor of Medicine at the University of Cincinnati College of Medicine. Dr. Henney served as the Senior Scholar at the Association of Academic Health Centers (AAHC) from 2001-2003. Before joining the AAHC, Dr. Henney served as the Commissioner of the U.S. Food and Drug Administration (FDA) from 1998-2001. From 1994-1998 she was Vice President for Health Sciences at the University of New Mexico. Dr. Henney worked at the FDA as Deputy Commissioner of Operations from 1992-1994. Before her time at the FDA, Dr. Henney served in a variety of senior leadership positions, including interim Dean of the College of Medicine at the University of Kansas School of Medicine. Prior to this position, Dr. Henney held a variety of positions at the National Cancer Institute including Deputy Director from 1980-1985. From 1976-1985, Dr. Henney served in a variety of roles at the National Institutes of Health (NIH), eventually becoming its Deputy Director in 1982. Dr. Henney received her undergraduate degree from Manchester College, her medical degree from Indiana University and her training in Oncology from M.D. Anderson Hospital and Tumor Institute. She currently sits on the board of directors for both AmerisourceBergen Corporation and CIGNA Corporation.
About Cubist
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address significant unmet medical needs in the acute care environment. Cubist is headquartered in Lexington, Mass. Additional information can be found at Cubist’s web site at www.cubist.com.